Wallington Asset Management Llc decreased Teva Pharmaceutical Industries (TEVA) stake by 50.12% reported in 2016Q4 SEC filing. Wallington Asset Management Llc sold 23,755 shares as Teva Pharmaceutical Industries (TEVA)’s stock declined 20.64%. The Wallington Asset Management Llc holds 23,640 shares with $857,000 value, down from 47,395 last quarter. Teva Pharmaceutical Industries now has $31.80B valuation. The stock decreased 0.47% or $0.15 on April 28, reaching $31.58. About shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 38.36% since September 22, 2016 and is downtrending. It has underperformed by 47.87% the S&P500.
Lawson Kroeker Investment Management Inc decreased Texas Pacific Land Trust (TPL) stake by 29.09% reported in 2016Q4 SEC filing. Lawson Kroeker Investment Management Inc sold 31,865 shares as Texas Pacific Land Trust (TPL)’s stock rose 23.95%. The Lawson Kroeker Investment Management Inc holds 77,681 shares with $23.05M value, down from 109,546 last quarter. Texas Pacific Land Trust now has $2.58B valuation. The stock increased 5.90% or $17.11 on April 28, reaching $307.11. About shares traded. Texas Pacific Land Trust (NYSE:TPL) has risen 39.90% since September 22, 2016 and is uptrending. It has outperformed by 30.39% the S&P500.
Wallington Asset Management Llc increased Vanguard Ftse Developed Market (VEA) stake by 149,579 shares to 507,179 valued at $18.53M in 2016Q4. It also upped Amazon.Com Inc. (NASDAQ:AMZN) stake by 440 shares and now owns 1,688 shares. Visa Inc. (NYSE:V) was raised too.
Analysts await Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) to report earnings on May, 11. They expect $1.03 EPS, down 12.71% or $0.15 from last year’s $1.18 per share. TEVA’s profit will be $1.04B for 7.67 P/E if the $1.03 EPS becomes a reality. After $1.36 actual EPS reported by Teva Pharmaceutical Industries Ltd (ADR) for the previous quarter, Wall Street now forecasts -24.26% negative EPS growth.
Among 24 analysts covering Teva Pharma (NYSE:TEVA), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Teva Pharma had 55 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Buy” rating by Maxim Group on Wednesday, January 4. The stock has “Outperform” rating by Cowen & Co on Wednesday, April 5. The rating was maintained by Maxim Group on Wednesday, November 16 with “Buy”. BTIG Research maintained the shares of TEVA in report on Friday, April 7 with “Neutral” rating. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, May 3. The stock has “Outperform” rating by Oppenheimer on Thursday, July 14. As per Thursday, August 25, the company rating was maintained by Mizuho. On Thursday, September 29 the stock rating was initiated by OTR Global with “Positive”. The rating was downgraded by Maxim Group to “Hold” on Friday, January 6. The company was downgraded on Wednesday, November 16 by Morgan Stanley.
